Table 1.

Demographics and baseline characteristics

CharacteristicTreatment schedule
S1 (n = 62)S2 (n = 4)S3 (n = 13)
Gender, n (%)Female30 (48)1 (25)7 (54)
Male32 (52)3 (75)6 (46)
Age, yMedian55.061.753.0
Range18.0–76.048–7128.0–69.0
ECOG PS, n (%)016 (26)04 (31)
144 (71)4 (100)8 (62)
22 (3)01 (8)
Tumor type, n (%)NSCLC17 (27)02 (15)
Other12 (19)2 (50)3 (23)
Sarcoma10 (16)01 (8)
Adrenocortical9 (15)1 (25)5 (38)
Carcinoma8 (13)02 (15)
Colorectal2 (3)00
Breast2 (3)00
Ovarian2 (3)00
Melanoma000
Renal01 (25)0
Prior lines of systemic therapy, n (%)0–216 (26)2 (50)4 (31)
3–526 (42)2 (50)9 (69)
6–76 (10)00
Prior radiation, n (%)No32 (52)1 (25)6 (46)
Yes30 (48)3 (75)7 (54)
Prior surgery, n (%)No20 (32)2 (50)4 (31)
Yes42 (68)2 (50)9 (69)
Prior endocrine, immunotherapy, and other agents, n (%)No59 (95)2 (50)13 (100)
Yes3 (5)2 (50)0

Abbreviations: ECOG PS, Eastern Cooperative Oncology Group performance status; s, schedule.